These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30666962)

  • 1. Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy.
    De Backer O; Lønborg J; Helqvist S; Warnøe J; Kløvgaard L; Holmvang L; Pedersen F; Tilsted HH; Raungaard B; Jørgensen E; Køber L; Høfsten DE; Kelbæk H; Engstrøm T
    EuroIntervention; 2019 Jun; 15(2):172-179. PubMed ID: 30666962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
    Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
    Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
    Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
    JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding episodes in "complete, staged" versus "culprit only" revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy.
    Sadjadieh G; Engstrøm T; Helqvist S; Høfsten DE; Køber L; Pedersen F; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Kelbæk H; Holmvang L
    EuroIntervention; 2016 Nov; 12(10):1231-1238. PubMed ID: 27866133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional flow reserve-guided PCI in patients with and without left ventricular hypertrophy: a DANAMI-3-PRIMULTI substudy.
    Sabbah M; Nepper-Christensen L; Lønborg J; Helqvist S; Køber L; Høfsten DE; Ahtarovski KA; Göransson C; Kyhl K; Schoos MM; Vejlstrup N; Kelbæk H; Engstrøm T
    EuroIntervention; 2020 Sep; 16(7):584-590. PubMed ID: 31746761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional flow reserve-guided complete revascularization versus culprit-only revascularization in acute ST-segment elevation myocardial infarction and multi-vessel disease patients: a meta-analysis and systematic review.
    Wang LJ; Han S; Zhang XH; Jin YZ
    BMC Cardiovasc Disord; 2019 Mar; 19(1):49. PubMed ID: 30823897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial.
    Smits PC; Laforgia PL; Abdel-Wahab M; Neumann FJ; Richardt G; Boxma-de Klerk B; Lunde K; Schotborgh CE; Piroth Z; Horak D; Wlodarczak A; Frederix GW; Omerovic E
    EuroIntervention; 2020 Jun; 16(3):225-232. PubMed ID: 32250250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
    Kim MC; Ahn JH; Hyun DY; Lim Y; Lee SH; Oh S; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JH; Lee SR; Kang DO; Hwang JY; Youn YJ; Jeong YH; Park Y; Kim DB; Choo EH; Kim CJ; Kim W; Rhew JY; Lee JH; Yoo SY; Ahn Y;
    Am Heart J; 2024 Jul; 273():35-43. PubMed ID: 38641031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial.
    Hong D; Lee SH; Lee J; Lee H; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC; Hong YJ; Jeong MH; Ahn SG; Doh JH; Lee SY; Don Park S; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY; Kang D; Lee JM;
    JAMA Netw Open; 2024 Jan; 7(1):e2352427. PubMed ID: 38270954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
    Diletti R; den Dekker WK; Bennett J; Schotborgh CE; van der Schaaf R; Sabaté M; Moreno R; Ameloot K; van Bommel R; Forlani D; van Reet B; Esposito G; Dirksen MT; Ruifrok WPT; Everaert BRC; Van Mieghem C; Elscot JJ; Cummins P; Lenzen M; Brugaletta S; Boersma E; Van Mieghem NM;
    Lancet; 2023 Apr; 401(10383):1172-1182. PubMed ID: 36889333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemia From Nonculprit Stenoses Is Not Associated With Reduced Culprit Infarct Size in Patients with ST-Segment-Elevation Myocardial Infarction.
    Ekström K; Nielsen JVW; Nepper-Christensen L; Ahtarovski KA; Kyhl K; Göransson C; Bertelsen L; Ghotbi AA; Kelbæk H; Høfsten DE; Køber L; Schoos MM; Vejlstrup N; Lønborg J; Engstrøm T
    Circ Cardiovasc Imaging; 2021 May; 14(5):e012290. PubMed ID: 33951923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
    Puymirat E; Simon T; de Bruyne B; Montalescot G; Steg G; Cayla G; Durand-Zaleski I; Blanchard D; Danchin N; Chatellier G;
    Am Heart J; 2020 Apr; 222():1-7. PubMed ID: 32000067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.
    Neupane S; Singh H; Edla S; Altujjar M; Yamsaki H; Lalonde T; Rosman HS; Eggebrecht H; Mehta RH
    Coron Artery Dis; 2019 Sep; 30(6):393-397. PubMed ID: 31094897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QFR Assessment and Prognosis After Nonculprit PCI in Patients With Acute Myocardial Infarction.
    Lee SH; Hong D; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC; Hong YJ; Ahn SG; Doh JH; Lee SY; Park SD; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Joh HS; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Jeong MH; Gwon HC; Hahn JY; Lee JM;
    JACC Cardiovasc Interv; 2023 Oct; 16(19):2365-2379. PubMed ID: 37821181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis.
    Archilletti F; Ricci F; Pelliccia F; Dangas G; Giuliani L; Radico F; Perfetti M; Rossi S; Gallina S; Maddestra N; Khanji MY; Zimarino M
    Int J Cardiol; 2023 Jan; 370():122-128. PubMed ID: 36328114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FFR-guided multivessel stenting reduces urgent revascularization compared with infarct-related artery only stenting in ST-elevation myocardial infarction: A meta-analysis of randomized controlled trials.
    Gupta A; Bajaj NS; Arora P; Arora G; Qamar A; Bhatt DL
    Int J Cardiol; 2018 Feb; 252():63-67. PubMed ID: 29249439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of fractional flow reserve in ST-elevation myocardial infarction culprit lesions.
    Hoole SP; Brown AJ; Jaworski C; McCormick LM; Clarke SC; West NE
    Coron Artery Dis; 2015 Sep; 26(6):495-502. PubMed ID: 26086865
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.